Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 3/20 | 0.51 |
| ▸ | TSHR | P16473 | 5/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16312317 | 0.83 | TSHR (0.57) | TSHRALDH1A1CYP3A4HTTGLA | |
| SCHEMBL8600740 | 0.81 | TSHR (0.55) | TSHRALDH1A1CYP3A4HTTGLA | |
| SCHEMBL8515067 | 0.81 | TSHR (0.55) | TSHRALDH1A1CYP3A4HTTGLA | |
| SCHEMBL1165645 | 0.80 | TSHR (0.53) | TSHRALDH1A1CYP3A4HTTGLA | |
| SCHEMBL14836356 | 0.80 | TSHR (0.53) | TSHRALDH1A1CYP3A4HTTGLA | |
| SCHEMBL11663143 | 0.80 | TSHR (0.53) | TSHRALDH1A1CYP3A4HTTGLA | |
| SCHEMBL362747 | 0.78 | TSHR (0.52) | TSHRALDH1A1CYP3A4HTTGLA | |
| SCHEMBL1515649 | 0.78 | TSHR (0.52) | TSHRALDH1A1CYP3A4HTTGLA | |
| SCHEMBL28673768 | 0.78 | FAAH (0.53) | TSHRALDH1A1CYP3A4HTTGLA | |
| SCHEMBL12180618 | 0.78 | TSHR (0.52) | TSHRALDH1A1CYP3A4HTTGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9976103-B2 | Lubricating composition containing an antiwear agent | THE LUBRIZOL CORPORATION (US) | 2018-05-22 | — | — | US | disclosed |
| EP-2513269-B1 | LUBRICATING COMPOSITION CONTAINING AN ANTIWEAR AGENT | LUBRIZOL CORP (US) | 2017-10-25 | — | — | EP | disclosed |
| US-9708563-B2 | Lubricating composition containing an antiwear agent | THE LUBRIZOL CORPORATION (US) | 2017-07-18 | — | — | US | disclosed |
| US-20150267140-A1 | LUBRICATING COMPOSITION CONTAINING AN ANTIWEAR AGENT | LUBRIZOL CORP (US) | 2015-09-24 | — | — | US | disclosed |
| US-20130172221-A1 | Lubricating Composition Containing an Antiwear Agent | THE LUBRIZOL CORPORATION (US) | 2013-07-04 | — | — | US | disclosed |
| US-20130042918-A1 | OLIGOTHIOPHENES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARIAL ORGANISATION | 2013-02-21 | — | — | US | disclosed |
| US-20130042918-A1 | OLIGOTHIOPHENES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARIAL ORGANISATION | 2013-02-21 | — | — | US | disclosed |
| US-20120309657-A1 | Lubricating Composition Containing an Antiwear Agent | THE LUBRIZOL CORPORATION (US) | 2012-12-06 | — | — | US | disclosed |
| US-20050059657-A1 | Aminoisoxazole derivatives active as kinase inhibitors | PFIZER ITALIA S.R.L. (IT) | 2005-03-17 | — | — | US | disclosed |
| EP-1435948-A1 | AMINOISOXAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS | Pharmacia Italia S.p.A. (IT) | 2004-07-14 | — | — | EP | disclosed |
| WO-2003013517-A1 | AMINOISOXAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS | PHARMACIA ITALIA S.P.A. (IT) | 2003-02-20 | — | — | WO | disclosed |
| US-4108630-A | 1-Alkylpyrid-2-ones | ROHM AND HAAS COMPANY (US) | 1978-08-22 | — | — | US | disclosed |
| US-4038065-A | 1-ALKYLPYRID-2-ONE | ROHM AND HAAS COMPANY (US) | 1977-07-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050059657-A1 | Aminoisoxazole derivatives active as kinase inhibitors | MAP3K9, MAP3K19, MAP4K2 | MCL1 584/4885TSHR 3971/4885ALDH1A1 4444/4885 |
| US-20130042918-A1 | OLIGOTHIOPHENES | NR0B2, NR2C2, NR1H2 | MCL1 2719/4885TSHR 63/4885ALDH1A1 1604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.